About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT02696252

G5® Mobile Continuous Glucose Monitoring System Automated vs. Manual Sensor Applicator

Comparison of G5® Mobile Continuous Glucose Monitoring System Accuracy When Using an Automated Applicator vs. a Manual Sensor Applicator

Lead sponsor: DexCom, Inc.•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

DexCom, Inc.

The objective of the study is to demonstrate the performance, i.e. efficacy of the G5x System with the automated applicator is no worse than that of the commercial Dexcom G4 TM PLATINUM Continuous Glucose Monitoring System (G4 System) with the manual applicator.

Age

2 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Ages 2 or older
•Diagnosis of Type 1 diabetes or Type 2 diabetes
•Willing to participate in a clinic session involving venous sampling for evaluation of study end point

Exclusion Criteria

•Use of acetaminophen
•Known allergy to medical-grade adhesives
•Pregnancy
•Hematocrit outside specification of the study-assigned blood glucose meter

Related studies

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT07232537 · Chronic Kidney Disease, Type 2 Diabetes Mellitus

Milk for Diabetes Prevention

NCT06513026 · Lactose Intolerance, Lactose Intolerant, and more

Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients

NCT07536516 · Diabetes Mellitus

RECRUITINGPhase 3

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

NCT07222137 · Diabetes Mellitus, Type 1

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 14, 2016Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment97

Start dateJan 2016

Last updatedApr 14, 2016

Condition

Diabetes Mellitus

Locations shown

AMCR Institute

Escondido, California

Rocky Mountain Diabetes and Osteoporosis Center

Idaho Falls, Idaho

Joslin Diabetes Center

Boston, Massachusetts

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 14, 2016Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions